![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 19, 2019 1:30:01 AM
And we had to find out about this through a prospectus and not through a courteous PR. My comments on IR still stand. Still a zero and waste of scarce resources. The only change is in the initials but IR is still overseen by LG, make no mistake about that.
As I said, probably NWBO has yet to submit the SAP to the four RAs. The pacing item will be RA reaction to the SAP which may involve time consuming back and forth. I also have a feeling that even with several hundred queries remaining, the data scrub is not yet completed and will also need to be done for continuing data collection until hard data lock. I believe that unblinding/top line will not happen until 2020 and that granular findings and analysis won't take place until ASCO 2020.
I believe that in the interim to unblinding/top line, there will be no substantive updates to support the share price. It will continue to bleed just as I predicted. Shortly before ASCO, we were at $0.34 and now we are below $0.23 barely a month and a half after the ASCO debacle. With continued fears of dilutive raises and silence wrt to unblinding/top line, the share price has nowhere but to go down. The shorts need not expend much energy in driving the pps down, NWBO is doing that very well by itself, thank you.
If this continues, I have little doubt that new lows will be reached. And, unfortunately, from a new low launching pad, the share price won't even reach a dollar even if top line is very positive. While I think long tail/milestones/subgroup results will be positive, there will be an overhang if the primary/secondary endpoints are mixed/unmet even though they should not matter as much as the long-tail, etc. The naysayers will focus on the former which may blunt any upward momentum.
The current raise was a hard hit to the solar plexus. Ouch. JMHO.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM